Skip to content

The efficacy of mixed intervention of metacognitive training and cognitive remediation on schizophrenia patients: a randomized clinical trial

The efficacy of mixed intervention of metacognitive training and cognitive remediation on schizophrenia patients: a randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068291
Enrollment
Unknown
Registered
2023-02-14
Start date
2023-02-14
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

MCT:META COGNITIVE TRAINING
MIX:META COGNITIVE TRAINING + COGNITIVE REMEDIATION
CONTROL GROUP:Treatment as usual

Sponsors

Department of Psychology, Southwest University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Must have a DSM--V- diagnosis of schizophrenia (this will be confirmed by the Psychotic Disorder subscale of the Mini-International Neuropsychiatric Interview or M.I.N.I); 2. Must maintain mild to moderate delusional beliefs as a minimum. This will be confirmed by the ‘Delusions’ subscale of the Positive and Negative Syndrome Scale (PANSS) and the Scale for the Assessment of Positive Symptoms (SAPS), and moderate to high scores on the Peters et al Delusions Inventory (PDI); 3. Must be able to speak, read and understand Chinese and have the ability to respond to questions and follow instructions.

Exclusion criteria

Exclusion criteria: 1. Diagnosed with substance use disorder, alcohol dependence within the past 6 months, IQ <70, severe organic brain disease, and epilepsy; 2. People whose primary language is not Chinese. To accurately confirm a diagnosis of schizophrenia and assess the severity of current delusions using clinical diagnostic measures, participants must be able to speak, read, and understand Chinese and have the ability to answer questions and follow instructions. Compromises in this area may lead to inaccurate diagnoses or misreporting of actual symptom severity; 3. Children and/or young adults (i.e., <18 years of age): manifestations of schizophrenia usually occur in the late teens and are often identified in the early 20s due to fluctuating symptoms. Exclusion of individuals under 18 years of age will ensure that the diagnosis of schizophrenia is valid; 4. People in a dependent or unequal relationship: To avoid any conflict of interest, people who are in a dependent or unequal relationship with the researcher will not be included in this study; 5. Women who are pregnant and the human foetus.

Design outcomes

Primary

MeasureTime frame
BACS (the Brief Assessment of Cognition in Schizophrenia);PANSS (the Positive and Negative Syndrome Scale) ;PSYRATS (the total score of the Psychotic Symptom Rating Scales) ;Beads Task;BADE Task;CRT (COGNITION REFLECTION TEST);

Countries

China

Contacts

Public ContactChen Hong

Department of Psychology, Southwest University

chenhg@swu.edu.cn+86 138 8322 4482

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026